MX336125B - Micro-organismos probioticos no replicantes que protegen a los niños frente a las infecciones gastrointestinales. - Google Patents

Micro-organismos probioticos no replicantes que protegen a los niños frente a las infecciones gastrointestinales.

Info

Publication number
MX336125B
MX336125B MX2013005370A MX2013005370A MX336125B MX 336125 B MX336125 B MX 336125B MX 2013005370 A MX2013005370 A MX 2013005370A MX 2013005370 A MX2013005370 A MX 2013005370A MX 336125 B MX336125 B MX 336125B
Authority
MX
Mexico
Prior art keywords
probiotic micro
replicating probiotic
gastrointestinal infections
organisms
protect children
Prior art date
Application number
MX2013005370A
Other languages
English (en)
Other versions
MX2013005370A (es
Inventor
Guénolée PRIOULT
Annick Mercenier
Clara Lucia Garcia-Rodenas
Sophie Nutten
Monique Julita
Valerie Petit
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43618887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX336125(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013005370A publication Critical patent/MX2013005370A/es
Publication of MX336125B publication Critical patent/MX336125B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una composición que comprende micro-organismos probióticos no replicantes, para usarse en la prevención o tratamiento de infecciones gastrointestinales en niños, donde los micro-organismos probióticos no replicantes fueron llevados a ser no replicantes por un tratamiento térmico a 120 hasta a 140° C por al menos 1-120 segundos. Y de 106 hasta 1012 ufc/g de la composición seca.
MX2013005370A 2010-11-11 2011-11-09 Micro-organismos probioticos no replicantes que protegen a los niños frente a las infecciones gastrointestinales. MX336125B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10190847A EP2455094A1 (en) 2010-11-11 2010-11-11 Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
PCT/EP2011/069693 WO2012062781A1 (en) 2010-11-11 2011-11-09 Non-replicating probiotic micro-organisms protect children against gastrointestinal infections

Publications (2)

Publication Number Publication Date
MX2013005370A MX2013005370A (es) 2013-06-28
MX336125B true MX336125B (es) 2016-01-07

Family

ID=43618887

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013005370A MX336125B (es) 2010-11-11 2011-11-09 Micro-organismos probioticos no replicantes que protegen a los niños frente a las infecciones gastrointestinales.

Country Status (16)

Country Link
US (1) US9345728B2 (es)
EP (2) EP2455094A1 (es)
CN (1) CN103282040A (es)
AU (1) AU2011328137A1 (es)
BR (1) BR112013011759A2 (es)
CA (1) CA2817407A1 (es)
CL (1) CL2013001313A1 (es)
ES (1) ES2542956T3 (es)
IL (1) IL226210A0 (es)
MX (1) MX336125B (es)
PL (1) PL2637677T3 (es)
PT (1) PT2637677E (es)
RU (1) RU2568830C2 (es)
SG (1) SG190170A1 (es)
WO (1) WO2012062781A1 (es)
ZA (1) ZA201304245B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2630299C2 (ru) 2011-06-20 2017-09-06 Г.Дж. Хайнц Компани Брэндс ЛЛК Композиции, способ и наборы для стимулирования мукозальной иммунной системы
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
WO2013192163A1 (en) 2012-06-18 2013-12-27 H.J. Heinz Company Gluten-related disorders
US9987316B2 (en) 2012-09-14 2018-06-05 Case Western Reserve University Probiotic controlling fungi and uses thereof
ES2729641T3 (es) 2013-05-10 2019-11-05 Heinz Co Brands H J Llc Probióticos y métodos de uso
CN110964665B (zh) * 2019-12-20 2020-09-25 哈尔滨美华生物技术股份有限公司 一种用于胃切除术后治疗的益生菌组合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124060T5 (es) 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
US6926891B1 (en) 1999-08-05 2005-08-09 Nestec S.A. Treatment of diarrhea with strains of Bifidobacterium longum
WO2001010453A2 (en) 1999-08-05 2001-02-15 Societe Des Produits Nestle S.A. Bifidobacteria capable of preventing diarrhea
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
CA2559813A1 (en) 2004-03-16 2005-09-22 Combi Co. Antidiarrheal agent for livestock and poultry
EP1743647B1 (en) * 2004-03-31 2016-12-28 Meiji Co., Ltd. Antibacterial composition
US7648270B2 (en) * 2004-04-02 2010-01-19 Avago Technologies General Ip (Singapore) Pte. Ltd. Temperature measurement of an integrated circuit
US7603432B2 (en) * 2005-06-06 2009-10-13 Aa, Llc Locality based alert method and apparatus
WO2008106372A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Method for treating or preventing systemic inflammation
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US9113641B2 (en) * 2007-12-06 2015-08-25 Arla Foods Amba Probiotic bacteria and regulation of fat storage
MX336030B (es) * 2009-05-11 2016-01-07 Nestec Sa Lactobacillus johnsonii la1 mcc533 (cncm i-1225) y padecimientos inmunes.
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
EP2251020A1 (en) 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
ES2565407T3 (es) * 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2449889A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Rice pudding preparations containing probiotic micro-organisms
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children

Also Published As

Publication number Publication date
US9345728B2 (en) 2016-05-24
RU2013126602A (ru) 2014-12-20
PL2637677T3 (pl) 2015-11-30
AU2011328137A1 (en) 2013-05-30
ZA201304245B (en) 2016-02-24
EP2637677A1 (en) 2013-09-18
RU2568830C2 (ru) 2015-11-20
SG190170A1 (en) 2013-06-28
IL226210A0 (en) 2013-07-31
CN103282040A (zh) 2013-09-04
BR112013011759A2 (pt) 2016-09-13
WO2012062781A1 (en) 2012-05-18
PT2637677E (pt) 2015-09-11
MX2013005370A (es) 2013-06-28
EP2637677B1 (en) 2015-06-17
CA2817407A1 (en) 2012-05-18
ES2542956T3 (es) 2015-08-13
EP2455094A1 (en) 2012-05-23
CL2013001313A1 (es) 2014-03-07
US20130224254A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
HK1216880A1 (zh) 某些三唑並吡啶化合物、其組合物和它們在治療癌症中的用途
WO2015095241A3 (en) Bacterial compositions and methods of use thereof for treatment of immune system disorders
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
IN2012DN01638A (es)
WO2011008092A3 (en) Gram-positive bacteria specific binding compounds
WO2010133475A3 (en) Infant feeding formulas comprising probiotic micro-organisms
WO2009095436A3 (en) Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof
UA109123C2 (uk) Пробіотична композиція для застосування в лікуванні запалення кишечнику
MX336125B (es) Micro-organismos probioticos no replicantes que protegen a los niños frente a las infecciones gastrointestinales.
MX2015000338A (es) Novedosa cepa de lactobacillus crispatus.
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
ZA201109086B (en) Prevention and treatment of allergic diarrhoea
EP2499134A4 (en) OXYGEN WASHERS, COMPOSITION COMPRISING THE WASHERS, AND ARTICLES MADE FROM THE COMPOSITIONS
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
PH12015501273B1 (en) Probiotic strains for the treatment and/or prevention of diarrhea
WO2012017321A3 (en) Treatment for dyslipidemia
EP2249843A4 (en) USE OF IMMUNOGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOGENIC INFECTIONS
MX349944B (es) Lactobacillus brevis productor de reuterina.
EP2453909A4 (en) ANTIGEN COMPOSITIONS AND METHODS OF INHIBITING BACTERIAL INFECTION BY JEJUNI CAMPYLOBACTER AND USES OF ANTIGEN COMPOSITIONS
GB201107068D0 (en) Prebiotic agent
TH153137A (th) จุลินทรีย์โปรไบโอติกที่ไม่แบ่งตัวปกป้องเด็กจากการติดเชื้อในทางเดินอาหาร
WO2011139254A3 (en) Pharmaceutical formulations compising cefuroxime axetil
AP2012006241A0 (en) Use of ferroquine in the treatment or prevention of malaria.